Researchers used a national cohort to describe the characteristics and clinical outcomes of maternity-associated infective endocarditis and to evaluate maternal and fetal outcomes of deliveries complicated by infective endocarditis.
Findings based on an online survey of more than 1,800 pregnant women
Women who stopped antidepressant treatment during pregnancy and resumed in the following weeks had a rebound effect of increased prescription of benzodiazepines and anxiolytics.
Pregnancy and insurance status were significant barriers to obtaining appointments for opioid use disorder treatment.
The CDC analyzed prescription opioid use during pregnancy via a self-reported survey.
Pregnancy was not linked to differences in survival outcomes.
Fifteen percent of pregnant women with COVID-19 have severe disease.
Risk for preterm delivery is higher in pregnant women who have experienced preeclampsia, placental abruption, stillbirth, neonatal death, or small for gestational age in a term first pregnancy.
Greater vegetable intake before pregnancy is associated with better birth outcomes.
Applying functional data analysis to continuous glucose monitoring data can assist in identifying differences in maternal glucose control during pregnancy, which might go unnoticed using standard metrics.
